Open- | Close- |
Vol / Avg.0 / 2.261K | Mkt Cap26.400K |
Day Range- - - | 52 Wk Range0.000 - 0.050 |
Acura Pharmaceuticals Stock (OTC: ACUR) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 2.261K | Mkt Cap26.400K |
Day Range- - - | 52 Wk Range0.000 - 0.050 |
Q3 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 1.324M |
Q2 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | ||||||
REV | 92.000K | 46.000K | -46.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2016-03-11 | Roth Capital | - | Initiates Coverage On | Buy | Announces | - | 6.00 |
2015-02-27 | MLV & Co. | - | Upgrades | HoldBuy | Maintains | - | 1.00 |
2014-05-28 | MLV & Co. | - | Downgrades | BuyHold | - | - | - |
2013-08-14 | McNicoll Lewis Vlak | - | Initiates Coverage On | Buy | Announces | - | 4.00 |
You can purchase shares of Acura Pharmaceuticals (OTCEM: ACUR) through any online brokerage.
There are no as such competitors for Acura Pharmaceuticals.
The latest price target for Acura Pharmaceuticals (OTCEM: ACUR) was reported by Roth Capital on Friday, March 11, 2016. The analyst firm set a price target for 6.00 expecting ACUR to rise to within 12 months (a possible 1499900.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Acura Pharmaceuticals (OTCEM: ACUR) is $0.0004 last updated September 26, 2023 at 1:32 PM UTC.
There is no dividend information for Acura Pharmaceuticals.
Acura Pharmaceuticals’s Q3 earnings are confirmed for Friday, February 28, 2020.
There is no upcoming split for Acura Pharmaceuticals.
Acura Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.
Acura Pharmaceuticals Stock (OTC: ACUR) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 2.261K | Mkt Cap26.400K |
Day Range- - - | 52 Wk Range0.000 - 0.050 |
Q3 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 1.324M |
Q2 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | ||||||
REV | 92.000K | 46.000K | -46.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2016-03-11 | Roth Capital | - | Initiates Coverage On | Buy | Announces | - | 6.00 |
2015-02-27 | MLV & Co. | - | Upgrades | HoldBuy | Maintains | - | 1.00 |
2014-05-28 | MLV & Co. | - | Downgrades | BuyHold | - | - | - |
2013-08-14 | McNicoll Lewis Vlak | - | Initiates Coverage On | Buy | Announces | - | 4.00 |
You can purchase shares of Acura Pharmaceuticals (OTCEM: ACUR) through any online brokerage.
There are no as such competitors for Acura Pharmaceuticals.
The latest price target for Acura Pharmaceuticals (OTCEM: ACUR) was reported by Roth Capital on Friday, March 11, 2016. The analyst firm set a price target for 6.00 expecting ACUR to rise to within 12 months (a possible 1499900.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Acura Pharmaceuticals (OTCEM: ACUR) is $0.0004 last updated September 26, 2023 at 1:32 PM UTC.
There is no dividend information for Acura Pharmaceuticals.
Acura Pharmaceuticals’s Q3 earnings are confirmed for Friday, February 28, 2020.
There is no upcoming split for Acura Pharmaceuticals.
Acura Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.
Acura Pharmaceuticals Stock (OTC: ACUR) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 2.261K | Mkt Cap26.400K |
Day Range- - - | 52 Wk Range0.000 - 0.050 |
Q3 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 1.324M |
Q2 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | ||||||
REV | 92.000K | 46.000K | -46.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2016-03-11 | Roth Capital | - | Initiates Coverage On | Buy | Announces | - | 6.00 |
2015-02-27 | MLV & Co. | - | Upgrades | HoldBuy | Maintains | - | 1.00 |
2014-05-28 | MLV & Co. | - | Downgrades | BuyHold | - | - | - |
2013-08-14 | McNicoll Lewis Vlak | - | Initiates Coverage On | Buy | Announces | - | 4.00 |
You can purchase shares of Acura Pharmaceuticals (OTCEM: ACUR) through any online brokerage.
There are no as such competitors for Acura Pharmaceuticals.
The latest price target for Acura Pharmaceuticals (OTCEM: ACUR) was reported by Roth Capital on Friday, March 11, 2016. The analyst firm set a price target for 6.00 expecting ACUR to rise to within 12 months (a possible 1499900.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Acura Pharmaceuticals (OTCEM: ACUR) is $0.0004 last updated September 26, 2023 at 1:32 PM UTC.
There is no dividend information for Acura Pharmaceuticals.
Acura Pharmaceuticals’s Q3 earnings are confirmed for Friday, February 28, 2020.
There is no upcoming split for Acura Pharmaceuticals.
Acura Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.
Acura Pharmaceuticals Stock (OTC: ACUR) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 2.261K | Mkt Cap26.400K |
Day Range- - - | 52 Wk Range0.000 - 0.050 |
Q3 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 1.324M |
Q2 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | ||||||
REV | 92.000K | 46.000K | -46.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2016-03-11 | Roth Capital | - | Initiates Coverage On | Buy | Announces | - | 6.00 |
2015-02-27 | MLV & Co. | - | Upgrades | HoldBuy | Maintains | - | 1.00 |
2014-05-28 | MLV & Co. | - | Downgrades | BuyHold | - | - | - |
2013-08-14 | McNicoll Lewis Vlak | - | Initiates Coverage On | Buy | Announces | - | 4.00 |
You can purchase shares of Acura Pharmaceuticals (OTCEM: ACUR) through any online brokerage.
There are no as such competitors for Acura Pharmaceuticals.
The latest price target for Acura Pharmaceuticals (OTCEM: ACUR) was reported by Roth Capital on Friday, March 11, 2016. The analyst firm set a price target for 6.00 expecting ACUR to rise to within 12 months (a possible 1499900.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Acura Pharmaceuticals (OTCEM: ACUR) is $0.0004 last updated September 26, 2023 at 1:32 PM UTC.
There is no dividend information for Acura Pharmaceuticals.
Acura Pharmaceuticals’s Q3 earnings are confirmed for Friday, February 28, 2020.
There is no upcoming split for Acura Pharmaceuticals.
Acura Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.
Acura Pharmaceuticals Stock (OTC: ACUR) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 2.261K | Mkt Cap26.400K |
Day Range- - - | 52 Wk Range0.000 - 0.050 |
Q3 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 1.324M |
Q2 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | ||||||
REV | 92.000K | 46.000K | -46.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2016-03-11 | Roth Capital | - | Initiates Coverage On | Buy | Announces | - | 6.00 |
2015-02-27 | MLV & Co. | - | Upgrades | HoldBuy | Maintains | - | 1.00 |
2014-05-28 | MLV & Co. | - | Downgrades | BuyHold | - | - | - |
2013-08-14 | McNicoll Lewis Vlak | - | Initiates Coverage On | Buy | Announces | - | 4.00 |
You can purchase shares of Acura Pharmaceuticals (OTCEM: ACUR) through any online brokerage.
There are no as such competitors for Acura Pharmaceuticals.
The latest price target for Acura Pharmaceuticals (OTCEM: ACUR) was reported by Roth Capital on Friday, March 11, 2016. The analyst firm set a price target for 6.00 expecting ACUR to rise to within 12 months (a possible 1499900.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Acura Pharmaceuticals (OTCEM: ACUR) is $0.0004 last updated September 26, 2023 at 1:32 PM UTC.
There is no dividend information for Acura Pharmaceuticals.
Acura Pharmaceuticals’s Q3 earnings are confirmed for Friday, February 28, 2020.
There is no upcoming split for Acura Pharmaceuticals.
Acura Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.
Acura Pharmaceuticals Stock (OTC: ACUR) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 2.261K | Mkt Cap26.400K |
Day Range- - - | 52 Wk Range0.000 - 0.050 |
Q3 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 1.324M |
Q2 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | ||||||
REV | 92.000K | 46.000K | -46.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2016-03-11 | Roth Capital | - | Initiates Coverage On | Buy | Announces | - | 6.00 |
2015-02-27 | MLV & Co. | - | Upgrades | HoldBuy | Maintains | - | 1.00 |
2014-05-28 | MLV & Co. | - | Downgrades | BuyHold | - | - | - |
2013-08-14 | McNicoll Lewis Vlak | - | Initiates Coverage On | Buy | Announces | - | 4.00 |
You can purchase shares of Acura Pharmaceuticals (OTCEM: ACUR) through any online brokerage.
There are no as such competitors for Acura Pharmaceuticals.
The latest price target for Acura Pharmaceuticals (OTCEM: ACUR) was reported by Roth Capital on Friday, March 11, 2016. The analyst firm set a price target for 6.00 expecting ACUR to rise to within 12 months (a possible 1499900.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Acura Pharmaceuticals (OTCEM: ACUR) is $0.0004 last updated September 26, 2023 at 1:32 PM UTC.
There is no dividend information for Acura Pharmaceuticals.
Acura Pharmaceuticals’s Q3 earnings are confirmed for Friday, February 28, 2020.
There is no upcoming split for Acura Pharmaceuticals.
Acura Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.
Acura Pharmaceuticals Stock (OTC: ACUR) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 2.261K | Mkt Cap26.400K |
Day Range- - - | 52 Wk Range0.000 - 0.050 |
Q3 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 1.324M |
Q2 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | ||||||
REV | 92.000K | 46.000K | -46.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2016-03-11 | Roth Capital | - | Initiates Coverage On | Buy | Announces | - | 6.00 |
2015-02-27 | MLV & Co. | - | Upgrades | HoldBuy | Maintains | - | 1.00 |
2014-05-28 | MLV & Co. | - | Downgrades | BuyHold | - | - | - |
2013-08-14 | McNicoll Lewis Vlak | - | Initiates Coverage On | Buy | Announces | - | 4.00 |
You can purchase shares of Acura Pharmaceuticals (OTCEM: ACUR) through any online brokerage.
There are no as such competitors for Acura Pharmaceuticals.
The latest price target for Acura Pharmaceuticals (OTCEM: ACUR) was reported by Roth Capital on Friday, March 11, 2016. The analyst firm set a price target for 6.00 expecting ACUR to rise to within 12 months (a possible 1499900.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Acura Pharmaceuticals (OTCEM: ACUR) is $0.0004 last updated September 26, 2023 at 1:32 PM UTC.
There is no dividend information for Acura Pharmaceuticals.
Acura Pharmaceuticals’s Q3 earnings are confirmed for Friday, February 28, 2020.
There is no upcoming split for Acura Pharmaceuticals.
Acura Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.
Acura Pharmaceuticals Stock (OTC: ACUR) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 2.261K | Mkt Cap26.400K |
Day Range- - - | 52 Wk Range0.000 - 0.050 |
Q3 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 1.324M |
Q2 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | ||||||
REV | 92.000K | 46.000K | -46.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2016-03-11 | Roth Capital | - | Initiates Coverage On | Buy | Announces | - | 6.00 |
2015-02-27 | MLV & Co. | - | Upgrades | HoldBuy | Maintains | - | 1.00 |
2014-05-28 | MLV & Co. | - | Downgrades | BuyHold | - | - | - |
2013-08-14 | McNicoll Lewis Vlak | - | Initiates Coverage On | Buy | Announces | - | 4.00 |
You can purchase shares of Acura Pharmaceuticals (OTCEM: ACUR) through any online brokerage.
There are no as such competitors for Acura Pharmaceuticals.
The latest price target for Acura Pharmaceuticals (OTCEM: ACUR) was reported by Roth Capital on Friday, March 11, 2016. The analyst firm set a price target for 6.00 expecting ACUR to rise to within 12 months (a possible 1499900.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Acura Pharmaceuticals (OTCEM: ACUR) is $0.0004 last updated September 26, 2023 at 1:32 PM UTC.
There is no dividend information for Acura Pharmaceuticals.
Acura Pharmaceuticals’s Q3 earnings are confirmed for Friday, February 28, 2020.
There is no upcoming split for Acura Pharmaceuticals.
Acura Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.
Acura Pharmaceuticals Stock (OTC: ACUR) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 2.261K | Mkt Cap26.400K |
Day Range- - - | 52 Wk Range0.000 - 0.050 |
Q3 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 1.324M |
Q2 2019 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | ||||||
REV | 92.000K | 46.000K | -46.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2016-03-11 | Roth Capital | - | Initiates Coverage On | Buy | Announces | - | 6.00 |
2015-02-27 | MLV & Co. | - | Upgrades | HoldBuy | Maintains | - | 1.00 |
2014-05-28 | MLV & Co. | - | Downgrades | BuyHold | - | - | - |
2013-08-14 | McNicoll Lewis Vlak | - | Initiates Coverage On | Buy | Announces | - | 4.00 |
You can purchase shares of Acura Pharmaceuticals (OTCEM: ACUR) through any online brokerage.
There are no as such competitors for Acura Pharmaceuticals.
The latest price target for Acura Pharmaceuticals (OTCEM: ACUR) was reported by Roth Capital on Friday, March 11, 2016. The analyst firm set a price target for 6.00 expecting ACUR to rise to within 12 months (a possible 1499900.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Acura Pharmaceuticals (OTCEM: ACUR) is $0.0004 last updated September 26, 2023 at 1:32 PM UTC.
There is no dividend information for Acura Pharmaceuticals.
Acura Pharmaceuticals’s Q3 earnings are confirmed for Friday, February 28, 2020.
There is no upcoming split for Acura Pharmaceuticals.
Acura Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.